Concepedia

123I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis

Walter Noordzij, Andor W.J.M. Glaudemans, Ronald W. J. van Rheenen, Bouke P. C. Hazenberg, René A. Tio, Rudi Dierckx, Riemer H. J. A. Slart

European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 60 citations · 19 references

DOIFull text

Open access

Abstract

MIBG HMR is lower and wash-out rate is higher in patients with echocardiographic signs of amyloidosis. Also, (123)I-MIBG scintigraphy can detect cardiac denervation in ATTR patients before signs of amyloidosis are evident on echocardiography.

References

19

The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement

Simon W Dubrey · QJM · 1998 · 565 citations · Full text

, , +15

Senile Systemic Amyloidosis Presenting With Heart Failure

Belinda Ng, Lawreen H. Connors, Ravin Davidoff et al. · Archives of Internal Medicine · 2005 · 369 citations

Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology

Albert Flotats, Ignasi Carrió, Denis Agostini et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 340 citations

, , +11

Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis

Rodney H. Falk, Jonathan F. Plehn, Thomas F. Deering et al. · The American Journal of Cardiology · 1987 · 216 citations

Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis

Allan L. Klein, Liv K. Hatle, Charles P. Taliercio et al. · Journal of the American College of Cardiology · 1990 · 179 citations

, , +8